Don’t Call it a Comeback: mHealth Never Went Out of Style

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Across the life sciences industry, global not-for-profit partnerships and pharmaceutical manufacturers alike have become increasingly active in the mobile health space.  In 2012, projections indicated that the global smartphone application market would reach up to $718 million. Already, mobile technologies had helped pharmaceutical and device teams facilitate heightened medical awareness and encourage patient adherence.  Continue reading


The Superstars of Digital Healthcare: MM&M Lists ‘Top 40 Healthcare Transformers’

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Innovations abound within the pharmaceutical digital marketing space. As a whole, the industry has worked to increase the availability of healthcare information and better address the needs of healthcare consumers. In its recent “Top 40 Healthcare Transformers” article, Medical Marketing and Media provides a snapshot of some of the leading industry innovators.  Many executives have leveraged online platforms to connect with unique industry stakeholders.  Others have modified the way patients receive healthcare by creating new—or rethinking existing— telemedicine platforms.  In some cases, companies have even begun connecting patients with doctors who are prepared to make house calls.  Continue reading


Big Data Storage and Privacy in the Pharmaceutical Industry

Victoria Cavicchi, pharmaceutical social media researcher
By Victoria Cavicchi,
Research Analyst

Within the last few years, Big Data has become one of the most recognizable buzzwords in marketing.  Especially as the healthcare industry moves more towards cultivating a strong digital presence, life sciences industries are looking for ways to use these data.  With access to a plethora of information — from electronic medical records (EMRs) to clinical trial results — firms are seeking out new ways to leverage pharmaceutical Big Data. Continue reading


Making the Most of Digital Marketing Budgets to Produce Valuable Initiatives

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Attaining and wisely spending online marketing budgets is essential for companies operating in the digital space.  How companies secure their digital marketing budgets and choose to spend them varies across surveyed pharmaceutical and device organizations. Some companies have a formal budgeting process in place for attaining digital marketing funding. Others receive budgets on an ad-hoc basis. Regardless of how these organizations receive their funding, allocating their available resources often marks the difference between companies abilities to develop successful, meaningful digital campaigns versus ones that fall flat after only a few months. Continue reading


Telemedicine’s Back. Tell A Friend.

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Telemedicine is back — and with good reason.  As it stands, patients can find visiting a doctor, especially for non-serious concerns, to be frustrating and time-consuming. Already, patients spend inordinate amounts of time traveling to and from physician offices just to spend more time in the doctors waiting room.  This patient-centric technology is poised to help healthcare consumers cut the time expenditure required to address minor health concerns.  With cold and flu season a not-so-distant memory, most end-users would agree that telemedicine is a useful tool for patients who are not in dire medical straits, but could still benefit from some key health advice. Continue reading